Cytomegalovirus inhibits CD14 expression on human alveolar macrophages

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 69-74

  Hopkins, Harvey A ^a,b   Monick, Marty M ^a   Hunninghake, Gary W ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CELL SURFACE RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOFLUORESCENCE MICROSCOPY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030056139     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.69     Document Type: Article

References (16)

1. Schooley R. Cytomegalovirus in the setting of infection with immunodeficiency virus. Rev Infect Dis 1990; 12(suppl):S811-9.
2. Rubin R. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12(suppl):S754-66.
3. Winston D, Winston G, Champlin R. Cytomegalovirus infections after allogeneic bone marrow transplantation. Rev Infect Dis 1990; 12(suppl): S776-91.
4. Rand K, Pollard R, Merigan T. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 1978;298:951-3.
5. Duncan S, Paradis I, Yousem A, et al. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 1992; 146:1419-25.
6. Chatterjee S, Fiala M, Weiner J, Stewart JA, Stacey B, Warner N. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA 1978;240:2446-9.
7. Rubin R, Cosimi A, Tokoff-Rubin N, Russell P, Hirsch M. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 1977;24:458-64.
8. Hamilton J, Overall J Jr, Glasgow L. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococais aureus, or Candida albicans infections. Infect Immun 1976;14:982-9.
9. Mackowiak P, Goggans M, Torres W, Nogare A, Luby J, Helderman H. Relationship between cytomegalovirus and colonization of the oropharynx by gram-negative bacilli following renal transplantation. Epidemiol Infect 1991;107:411-20.
10. Sibille Y, Reynolds H. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990;141:471-501.
11. Paradis I, Grgurich W, Dummer J, Dekker A, Dauber J. Rapid detection of cytomegalovirus pneumonia from lung lavage cells. Am Rev Respir Dis 1988;138:697-702.
12. Drew W, Mintz L, Hoo R, Finley T. Growth of herpes simplex and cytomegalovirus in cultured human alveolar macrophages. Am Rev Respir Dis 1979;119:287-91.
13. Ibanez C, Schrier R, Ghazal P, Wiley C, Nelson J. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991; 65:6581-8.
14. Morrison D, Ryan J. Endotoxin and disease mechanism. Annu Rev Med 1987;38:417-32.
15. Todd R III, Nadler L, Schlossman S. Antigens on human monocytes identified by monoclonal antibodies. J Immunol 1981;126:1435-42.
16. Hance A, Douches S, Winchester R, Ferrans V, Crystal R. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J Immunol 1985;134:284-92.